CA Piccirillo, EM Shevach. (2001) "Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells." J Immunol 167. 1137-40 PMID: 11466326 | Abstract and Keywords
OF Bathe, N Dalyot-Herman, TR Malek. (2001) "IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells." J Immunol 167. 4511-7 PMID: 11591778 | Abstract and Keywords
JA Toomey, F Gays, D Foster, CG Brooks. (2003) "Cytokine requirements for the growth and development of mouse NK cells in vitro." J Leukoc Biol 74. 233-42 PMID: 12885940 | Abstract and Keywords
N Dikopoulos, A Bertoletti, A Kröger, H Hauser, R Schirmbeck, J Reimann. (2005) "Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells." J Immunol 174. 99-109 PMID: 15611232 | Abstract and Keywords
T Boettler, HC Spangenberg, C Neumann-Haefelin, E Panther, S Urbani, C Ferrari, HE Blum, F von Weizsäcker, R Thimme. (2005) "T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection." J Virol 79. 7860-7 PMID: 15919940 DOI: 10.1128/JVI.79.12.7860-7867.2005 | Abstract and Keywords
C Kudo-Saito, J Schlom, K Camphausen, CN Coleman, JW Hodge. (2005) "The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors." Clin Cancer Res 11. 4533-44 PMID: 15958639 DOI: 10.1158/1078-0432.CCR-04-2237 | Abstract and Keywords
KL Knutson, Y Dang, H Lu, J Lukas, B Almand, E Gad, E Azeke, ML Disis. (2006) "IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice." J Immunol 177. 84-91 PMID: 16785502 | Abstract and Keywords